Sees FY23 ZILRETTA net product sales $115M-$125M. iovera net product sales $17M-$20M.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PCRX:
- Pacira BioSciences Reports First Quarter 2023 Financial Results
- Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
- Pacira price target lowered to $62 from $63 at Piper Sandler
- Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
- Pacira partners with the Invited Celebrity Classic